Prognostic marker CD27 and its micro-environmental in multiple myeloma
Abstract Background The Cluster of Differentiation 27 (CD27) is aberrantly expressed in multiple myeloma (MM) -derived. This expression facilitates the interaction between tumor and immune cells within TME via the CD27-CD70 pathway, resulting in immune evasion and subsequent tumor progression. The o...
Main Authors: | Xinya Wang, Keyang Luo, Qiuting Xu, Liqun Chi, Yiwei Guo, Chuiming Jia, Lina Quan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-11945-z |
Similar Items
-
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
by: Noa Gross Even-Zohar, et al.
Published: (2022-05-01) -
PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2022-05-01) -
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01) -
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
by: Piotr Łacina, et al.
Published: (2022-01-01) -
HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
by: Lina Quan, et al.
Published: (2022-11-01)